Back
Mainstreet Equity Vs. Aligos Therapeutics Industry Stock Comparison
Buy
62
MEQ.TO
Mainstreet Equity
Last Price:
208.99
Seasonality Move:
13.38%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Buy
62
Mainstreet Equity (MEQ.TO)
is a Buy
Is Mainstreet Equity a Buy, Sell or Hold?
- The current Mainstreet Equity [MEQ.TO] share price is $208.99. The Score for MEQ.TO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MEQ.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MEQ.TO Stock Price Chart
What is Mainstreet Equity's stock price today?
-
The Mainstreet Equity share price today is $208.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEQ.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MEQ.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 62.32 | Buy |
| Chaikin Money Flow: | 4284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (198.52 - 204.9) | Buy |
| Bollinger Bands (100): | (191.27 - 203.25) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.71 | Buy |
| Relative Strength Index (14 RSI): | 85.17 | Buy |
| Chaikin Money Flow: | 491004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.08 - 27.66) | Buy |
| Bollinger Bands (100): | (7.67 - 19.61) | Buy |
MEQ.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 201.94 | Buy |
| 20-day SMA: | 201.2 | Buy |
| 50-day SMA: | 201.63 | Buy |
| 200-day SMA: | 186.48 | Buy |
| 8-day EMA: | 203.61 | Buy |
| 20-day EMA: | 202.34 | Buy |
| 50-day EMA: | 200.48 | Buy |
| 200-day EMA: | 185.21 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.48 | Buy |
| 20-day SMA: | 23.64 | Buy |
| 50-day SMA: | 14.76 | Buy |
| 200-day SMA: | 15.86 | Buy |
| 8-day EMA: | 28.77 | Buy |
| 20-day EMA: | 23.99 | Buy |
| 50-day EMA: | 18.16 | Buy |
| 200-day EMA: | 16.13 | Buy |
Mainstreet Equity Earnings Growth & MEQ.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.23 per share, and an increase next year of $7.54 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Mainstreet Equity Technical Analysis
| Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||